- Report
- September 2025
- 250 Pages
Global
From €3952EUR$4,490USD£3,448GBP
- Report
- September 2025
- 250 Pages
Global
From €3952EUR$4,490USD£3,448GBP
- Report
- September 2025
- 250 Pages
Global
From €3952EUR$4,490USD£3,448GBP
- Report
- June 2025
- 400 Pages
Global
From €4356EUR$4,949USD£3,800GBP
- Report
- July 2023
- 145 Pages
Global
From €2773EUR$3,150USD£2,419GBP
- Report
- January 2024
- 150 Pages
Global
From €3389EUR$3,850USD£2,956GBP
€4269EUR$4,850USD£3,724GBP
- Report
- May 2023
- 74 Pages
Global
From €3500EUR$4,259USD£3,160GBP
- Report
- December 2023
- 300 Pages
Global
From €1100EUR$1,250USD£960GBP
€2201EUR$2,500USD£1,920GBP
- Report
- December 2023
- 80 Pages
Russia
From €1320EUR$1,500USD£1,152GBP
- Report
- December 2023
- 80 Pages
Poland
From €1320EUR$1,500USD£1,152GBP
- Report
- October 2023
- 300 Pages
Global
From €1100EUR$1,250USD£960GBP
€2201EUR$2,500USD£1,920GBP
- Report
- October 2023
- 100 Pages
Africa
From €1761EUR$2,000USD£1,536GBP
- Report
- October 2023
- 80 Pages
United States
From €1320EUR$1,500USD£1,152GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €1320EUR$1,500USD£1,152GBP
From €1320EUR$1,500USD£1,152GBP
- Report
- October 2023
- 80 Pages
South Korea
From €1320EUR$1,500USD£1,152GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €1320EUR$1,500USD£1,152GBP
- Report
- October 2023
- 80 Pages
India
From €1320EUR$1,500USD£1,152GBP
- Report
- October 2023
- 80 Pages
Germany
From €1320EUR$1,500USD£1,152GBP
- Report
- October 2023
- 80 Pages
France
From €1320EUR$1,500USD£1,152GBP

Liothyronine is a synthetic form of the thyroid hormone triiodothyronine (T3). It is used to treat hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormone. It is also used to treat goiter, an enlarged thyroid gland, and to treat thyroid cancer. Liothyronine is a part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions related to hormones and metabolism. These drugs are used to treat conditions such as diabetes, obesity, and thyroid disorders.
Liothyronine is available in both brand-name and generic forms. It is available as a tablet, capsule, and liquid solution. It is usually taken once a day, but the dosage and frequency may vary depending on the patient's condition.
Companies in the Liothyronine market include AbbVie, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more